Ignite Creation Date:
2024-05-05 @ 11:23 AM
Last Modification Date:
2024-10-26 @ 9:06 AM
Study NCT ID:
NCT00025532
Status:
WITHDRAWN
Last Update Posted:
2012-09-14
First Post:
2001-10-11
Brief Title:
Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Gastrointestinal Cancer
Sponsor:
University of California San Francisco
Organization:
University of California San Francisco
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Colorectal Cancer |
| Gastric Cancer |
| Pancreatic Cancer |
| Esophageal Cancer |
Keywords:
| Name | View |
|---|---|
| stage IV colon cancer | View |
| stage III gastric cancer | View |
| stage IV gastric cancer | View |
| recurrent gastric cancer | View |
| stage III pancreatic cancer | View |
| recurrent pancreatic cancer | View |
| stage III rectal cancer | View |
| stage IV rectal cancer | View |
| recurrent colon cancer | View |
| recurrent rectal cancer | View |
| stage IV esophageal cancer | View |
| recurrent esophageal cancer | View |
| adenocarcinoma of the stomach | View |
| adenocarcinoma of the esophagus | View |
| adenocarcinoma of the colon | View |
| adenocarcinoma of the rectum | View |
| adenocarcinoma of the pancreas | View |
| stage IV pancreatic cancer | View |
| stage III colon cancer | View |
| stage III esophageal cancer | View |